Robin Joyce
Overview
Explore the profile of Robin Joyce including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
34
Citations
1396
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Maguire W, Haley P, Dietz C, Hoffelder M, Brandt C, Joyce R, et al.
JID Innov
. 2023 Mar;
3(2):100181.
PMID: 36960318
The documentation of the change in the number and appearance of pigmented cutaneous lesions over time is critical to the early detection of skin cancers and may provide preliminary signals...
2.
Koshy A, Kim H, Liegel J, Arnason J, Ho V, Antin J, et al.
Blood
. 2023 Mar;
141(24):2932-2943.
PMID: 36862975
Steroid-refractory chronic graft-versus-host disease (cGVHD) after allogeneic transplant remains a significant cause of morbidity and mortality. Abatacept is a selective costimulation modulator, used for the treatment of rheumatologic diseases, and...
3.
Al-Yousif N, Komanduri S, Qurashi H, Korzhuk A, Lawal H, Abourizk N, et al.
BMJ Open
. 2023 Jan;
13(1):e066626.
PMID: 36635036
Objectives: To reliably quantify the radiographic severity of COVID-19 pneumonia with the Radiographic Assessment of Lung Edema (RALE) score on clinical chest X-rays among inpatients and examine the prognostic value...
4.
Weinstock M, Elavalakanar P, Bright S, Ambati S, Brouwer-Visser J, Pourpe S, et al.
Br J Haematol
. 2022 Jul;
199(3):366-370.
PMID: 35892294
Outcomes remain poor for patients with relapsed/refractory B-cell non-Hodgkin lymphoma (R/R B-NHL). While chimeric antigen receptor (CAR) T-cell therapy has revolutionised treatment, a significant proportion of patients relapse or fail...
5.
Al-Yousif N, Komanduri S, Qurashi H, Korzhuk A, Lawal H, Abourizk N, et al.
medRxiv
. 2022 Jun;
PMID: 35734089
Introduction: Chest imaging is necessary for diagnosis of COVID-19 pneumonia, but current risk stratification tools do not consider radiographic severity. We quantified radiographic heterogeneity among inpatients with COVID-19 with the...
6.
Lee H, Joyce R, Lee J
ACS Appl Mater Interfaces
. 2022 Jan;
14(4):5983-5994.
PMID: 35043613
Conventional methods for measuring the various dimensions of a fruit vary from vernier calipers to machine vision systems. This accounts for system bulkiness, high installation charges, and miscellaneous difficulties in...
7.
Rutherford S, Abramson J, Bartlett N, Barta S, Khan N, Joyce R, et al.
Lancet Haematol
. 2021 Oct;
8(11):e818-e827.
PMID: 34634256
Background: Dose-adjusted EPOCH-R (etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin, and rituximab) is a front-line treatment for patients with aggressive B-cell lymphomas. Bcl-2 is associated with chemoresistance due to BCL2 gene rearrangement...
8.
Patell R, Khan A, Bogue T, Merrill M, Koshy A, Bindal P, et al.
Am J Hematol
. 2020 Jul;
95(10):E295-E296.
PMID: 32658337
No abstract available.
9.
Zwicker J, Roopkumar J, Puligandla M, Schlechter B, Sharda A, Peereboom D, et al.
Blood Adv
. 2020 May;
4(10):2254-2260.
PMID: 32442298
Hospitalized patients with cancer are at an increased risk of developing venous thromboembolism (VTE). The recommendation for routine pharmacologic thromboprophylaxis in hospitalized patients with cancer to prevent VTE is based...
10.
Merryman R, Edwin N, Redd R, Bsat J, Chase M, LaCasce A, et al.
Blood Adv
. 2020 Mar;
4(5):858-867.
PMID: 32126141
The addition of high-dose cytarabine to rituximab/bendamustine (RB) induction could improve outcomes for transplant-eligible patients with mantle cell lymphoma (MCL). We conducted a pooled analysis of 2 phase 2 trials...